NCT01948622

Anxiety Control by Erythrina Mulungu

Anxiety Control by Using Erythrina Mulungu in Mandibular Third Molars Extraction

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Liane Maciel de Almeida Souza · Academic / Other
• Sex: All
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

This study evaluated the effectiveness of the Erythrina mulungu in controlling anxiety in patients undergoing bilateral extraction of asymptomatic, impacted mandibular third molars.

Detailed description

: In this research, characterized as a randomized, double-blind, crossover study, 30 healthy volunteered patients (05 men and 25 women) aged 18 or older who received a capsule of 500mg of Mulungu Matusa ® or placebo, orally, one hour before the procedure were selected. The level of anxiety was assessed through questionnaires and physical parameters, such as blood pressure, heart rate and oxygen concentration. Data were collected, tabulated and analyzed by the following statistical tests: chi-square, t-test, ANOVA and Tukey test, Friedman, Fisher's exact test with significance level of 5%.

Conditions

• Dental Anxiety
• Impacted Third Molar Tooth

Interventions

Type	Name	Description
DRUG	Mulungu	500 mg/single dose/1 hour before dental surgery
DRUG	Placebo	500 mg/single dose/1 hour before dental surgery

Timeline

• Start date: 2012-01-01
• Primary completion: 2012-06-01
• Completion: 2012-11-01
• First posted: 2013-09-23
• Last updated: 2013-09-23

Locations

1 site across 1 country: Brazil